WASHINGTON — The Trump administration’s proposal to nearly eliminate funding for White House office tasked with overseeing the nation’s opioid fight is getting fast and firm pushback from the Senate.

A bipartisan group of 13 lawmakers, led by Senators Chuck Grassley (R-Iowa) and Dianne Feinstein (D-Calif.), warned President Trump this week that reducing the Office of National Drug Control Policy’s budget by nearly 95 percent would derail the fight against the opioid epidemic, hamper law enforcement efforts, and cost the government money in the long run.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy